`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
` Paper No. ____
`Filed: October 12, 2016
`
`
`
`
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`__________________
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`__________________
`LUPIN LTD. and LUPIN PHARMACEUTICALS INC., INNOPHARMA
`LICENSING, INC., INNOPHARMA LICENSING LLC, INNOPHARMA INC.,
`INNOPHARMA LLC, MYLAN PHARMACEUTICALS INC., and MYLAN INC.
`Petitioner
`
`v.
`
`
`
`
`
` SENJU PHARMACEUTICAL CO., LTD.,
`Patent Owner
`_________________
`Case IPR2015-01105 (Patent 8,871,813 B2)1
`
`
`
`
`
`
`JOINT STIPULATION AND COUNSEL CERTIFICATION
`REGARDING CONFIDENTIAL INFORMATION
`CITED IN FINAL WRITTEN DECISION
`
`
`
`
`1 Case IPR2016-00090 has been joined with this proceeding.
`
`
`
`Case IPR2015-01105
`Patent No. 8,871,813
`
`In the Order of September 15, 2016, the Board ordered the partiesto file a
`
`joint stipulation that identifies with particularity the exact portions (by page or
`
`paragraph number) of all sealed papers and exhibits that are cited in the Final
`
`Written Decision. (Paper No. 73 at 6-8.)
`
`I.
`
`Joint Stipulation Regarding Confidential Information Cited in Final
`Written Decision
`
`Accordingly, the parties have conferred and agree that the following pages
`
`or paragraphs ofpapers or exhibits, containing sealed confidential information, are
`
`cited in the Final Written Decision, as indicated below:
`
`Sealed Paperor
`
`Portion Cited in Final
`
`Citation(s) in
`
`Exhibit No.
`
`Written Decision
`
`Final Written Decision
`
`pp. 10, 19, 25, 36, 43
`
`Patent Owner Response
`
`(Paper No. 23)
`
`pp. 10, 19, 25, 36, 38, 43
`
`* While the Final Written Decision cites generally to Patent Owner’s Response
`
`without differentiating between the confidential and public versions (see Final
`
`Written Decision, Paper 70 at 2), it cites to information found in the confidential
`
`version of this pleading. (See Paper No. 23.)
`
`
`
`Case IPR2015-01105
`Patent No. 8,871,813
`
`Sealed Paper or
`
`Portion Cited in Final
`
`Citation(s) in
`
`Exhibit No.
`
`Written Decision
`
`Final Written Decision
`
`| 36
`
`p.4—
`
`(Ex. 2082)
`
`——Declaration Se200pI1154
`
`Hofmann Declaration
`
`(Ex. 1122)
`
`ee
`
`{68
`
`469
`
`p. 39
`
`p. 39
`
`Pe
`
`
`
`
`
`Case IPR2015-01105
`Patent No. 8,871,813
`
`Sealed Paper or
`
`Portion Cited in Final
`
`Citation(s) in
`
`Exhibit No.
`
`Written Decision
`
`Final Written Decision
`
`
`
`Jarosz Declaration
`
`_
`
`pp. 38, 40
`
`_
`
`Revised, redacted public versions of the Patent Owner’s Response, and Exs.
`
`1122, 1154, 2082, and 2130 will be filed by the Board’s deadline, and the pages
`
`and paragraphsidentified above will not be redacted.
`
`Il.
`
`Counsel Certification
`
`Counselfor Petitioner and Patent Ownerattest to the accuracy and
`
`completeness of the above Joint Stipulation. Counsel for Petitioner and Patent
`
`Ownerfurther verify that the exact portion of each paper and exhibit cited in the
`
`Final Written Decisionis identified (by page or paragraph number) in the above
`
`Joint Stipulation.
`
`Date: October 12, 2016
`
`Respectfully submitted,
`
`
`
`By: /Deborah Yellin/
`
`Deborah Yellin, Lead Counsel
`Reg. No. 45,904
`Jonathan Lindsay, Back-up Counsel
`Reg. No. 45,810
`Teresa Stanek Rea, Back-up Counsel
`Reg. No. 30,427
`CROWELL & MORING LLP
`Intellectual Property Group
`1001 Pennsylvania Avenue, N.W.
`Washington, DC 20004-2595
`Telephone: (202) 624-2947
`Fax: (202) 628-8844
`
`Chiemi Suzuki
`CROWELL & MORING LLP
`Intellectual Property Group
`590 Madison Avenue, 20th Floor
`New York, NY 10022-2524
`Telephone: (212) 803-4050
`Fax: (212) 223-4134
`
`Counsel for Petitioners
`
` By: /Jitendra Malik/
`
`Jitendra Malik, Lead Counsel
`Reg. No. 55,823
`Bryan Skelton, Ph.D.
`Reg No. 50,893
`ALSTON & BIRD LLP
`4721 Emperor Boulevard, Suite 400
`Durham, NC 27703
`Telephone: (919) 862-2200
`Fax: (919) 862-2260
`
`
`
`
`
`Case IPR2015-01105
`Patent No. 8,871,813
`
`
`Lance Soderstrom
`Reg No. 65,405
`ALSTON & BIRD LLP
`90 Park Avenue
`15th Floor
`New York, NY 10016-1387
`Telephone: (212) 210-9400
`Fax: (212) 210-9444
`
`
`Hidetada James Abe
`Reg. No. 61,182
`ALSTON & BIRD LLP
`333 South Hope Street, 16th Floor
`Los Angeles, CA 90071
`Telephone: (213) 576-1000
`
`Counsel for Petitioner
`InnoPharma
`By: /Bryan C. Diner/
`Bryan C. Diner, Lead Counsel
`Reg. No. 32,409
`Justin J. Hasford, Back-up Counsel
`Reg. No. 62,180
`Joshua L. Goldberg, Back-up Counsel
`Reg. No. 59,369
`FINNEGAN, HENDERSON,
`FARABOW, GARRETT &
`DUNNER LLP
`901 New York Ave. NW
`Washington, DC 20001-4413
`Telephone: (202) 408-4000
`
`Counsel for Patent Owner
`
`
`
`
`
`5
`
`
`
`CERTIFICATE OF SERVICE
`
`Case IPR2015-01105
`Patent No. 8,871,813
`
`
`The undersigned hereby certifies that a copy of the foregoing Joint
`
`Stipulation and Counsel Certification Regarding Confidential Information
`
`Cited in Final Written Decision was served on October 12, 2016, via email
`
`directed to counsel of record for the Petitioner at the following:
`
`Deborah Yellin
`DYellin@crowell.com
`
`Jonathan Lindsay
`JLindsay@crowell.com
`
`Teresa Stanek Rea
`TRea@crowell.com
`
`Chiemi Suzuki
`CSuzuki@crowell.com
`
`Shannon Lentz
`SLentz@crowell.com
`
`Jitendra Malik
`jitty.malik@alston.com
`
`Bryan Skelton, Ph.D.
`Bryan.skelton@alston.com
`
`Lance Soderstrom
`Lance.soderstrom@alston.com
`
`Hitetada James Abe
`James.abe@alston.com
`
`Joseph M. Janusz
`Joe.janusz@alston.com
`
`6
`
`
`
`
`
`
`
`Date: October 12, 2016
`
`
`
`
`
`
`Case IPR2015-01105
`Patent No. 8,871,813
`
`
`/Bradley J. Moore/
`Bradley J. Moore
`Litigation Legal Assistant
`Finnegan, Henderson, Farabow, Garrett &
`Dunner, LLP
`
`
`
`7
`
`